CAS: 1146699-66-2 - Pentanamide,2-[[(4-chlorophenyl)sulfonyl][[2-fluoro-4-(1,2,4-oxadiazol-3-yl)phenyl]methyl]amino]-5,5,5-trifluoro-,(2R)-

Formel: C₂₀H₁₇ClF₄N₄O₄S

Synonyme:

• (2R)-2-[N-[(4-Chlorophenyl)sulfonyl]-N-[[2-fluoro-4-(1,2,4-oxadiazol-3-yl)phenyl]methyl]amino]-5,5,5-trifluoropentanamide
• (2R)-2-[(4-chlorophenyl)sulfonyl-[[2-fluoro-4-(1,2,4-oxadiazol-3-yl)phenyl]methyl]amino]-5,5,5-trifluoro-pentanamide
• Avagacestat
• Bms-708163

Pentanamide, 2-[[(4-chlorophenyl)sulfonyl][[2-fluoro-4-(1,2,4-oxadiazol-3-yl)phenyl]methyl]amino]-5,5,5-trifluoro-, (2R)-

CAS: 1146699-66-2

• Formel: C₂₀H₁₇ClF₄N₄O₄S
• Reinheit: 98+%
• Farbe und Form: Solid
• Molekulargewicht: 520.8850

Avagacestat

CAS: 1146699-66-2

Avagacestat (BMS-708163) (BMS-708163) is a potent, selective, orally bioavailable γ-secretase inhibitor of Aβ40 and Aβ42 …

• Formel: C₂₀H₁₇ClF₄N₄O₄S
• Reinheit: 99.77%
• Farbe und Form: Solid
• Molekulargewicht: 520.89

(R)-2-[[4-chlorophenyl)sulfonyl][[2-fluoro-4-(1,2,4-oxadiazol-3-yl)phenyl]methyl]amino]-5,5,5-trifluoropentanamide

CAS: 1146699-66-2

Applications Avagacestat acts as a γ-secretase inhibitor allowing for treatment of ALzheimer’s disease. On addition …

• Formel: C₂₀H₁₇ClF₄N₄O₄S
• Farbe und Form: Neat
• Molekulargewicht: 520.88

BMS 708163

CAS: 1146699-66-2

Inhibitor of γ-secretase; Alzheimer's disease treatment

• Formel: C₂₀H₁₇ClF₄N₄O₄S
• Reinheit: Min. 95%
• Molekulargewicht: 520.89 g/mol